-
Labour rival eyes win in poll key to UK PM's fate
-
Haiti's World Cup return lifts community in New York
-
McIlroy grabs early lead at fog-hit US Open
-
Trump's Iran deal sparks anger among Republican hawks
-
Swiss heading towards referendum on new nuclear plants
-
Grand Theft Auto VI presales to begin next week
-
Novelist Kundera and wife buried in Czech home city
-
Hegseth blasts NATO allies, says US will review forces in Europe
-
Cuban economy needs 'urgent changes' to overcome crisis: president
-
Greenland sees wildfires earlier in the year
-
US Open resumes after two-hour fog delay
-
The vaccines and treatments being developed for Ebola outbreak
-
Spanish king to visit Mexican president on June 25 as ties improve
-
Ton-up Phillips stars for New Zealand against England
-
Wahi denied Canadian visa for Ivory Coast World Cup clash with Germany
-
Swiss central bank holds interest rates, with eye on currency risks
-
S.African sentenced in 'world's largest' rhino trafficking case
-
Bank of England follows Fed in holding interest rate
-
Bittersweet World Cup for Gaza's football fans
-
Trump defends Iran deal from critics he calls 'fools'
-
New heatwave disrupts trains, schools in France
-
German chemical company to cut 3,200 jobs as crisis worsens
-
Starmer's Labour rival eyes win in UK poll key to PM's fate
-
Oil falls further on Mideast deal, but Fed outlook knocks equities
-
Mexico, Korea eye World Cup knockout berths
-
Range raises $8.3M Series A to unify treasury, risk and compliance across stablecoins and fiat
-
IAEA ready to help define 'concrete steps' to implement US-Iran deal
-
Ibrahima Konate signs four-year deal with Real Madrid
-
Hegseth tells NATO US will review force presence in Europe
-
Innovations on show at Paris Vivatech fest
-
Ukraine sets Moscow refinery ablaze in biggest attack in years
-
Bird flu kills 13,000 seal pups on remote Australian island
-
Oil prices sink further as Trump signs deal to reopen Hormuz
-
South Korean lawmakers launch probe into ballot paper shortages
-
Starmer rival seeks win in UK poll pivotal to PM's fate
-
Taiwan president says hopes for $14 bn US arms sale 'as soon as possible'
-
Why are Kenyan kids burning schools and killing their classmates?
-
New wave of anti-LGBTQ laws sweeps Africa
-
Ukraine hopes renewables can Russia-proof power grid
-
Jubilant New York on guard for Knicks parade
-
What we learned after the first round of World Cup games
-
New Zealander Manu has 'no fear' of Toulouse before Top 14 semi
-
Drastic restrictions on public transport take effect in Cuba
-
Pain-riddled South Korean man fights for right to die
-
Cuba approves economic reforms to boost private sector, investment: state TV
-
India learns to live with hotter summers
-
'Retired' Wallaby Slipper, 37, set for shock international comeback
-
EU wrestles over how to tackle China export flood
-
Tartan Army takes over Boston as Scotland fans relish World Cup return
-
Comedian Jordan Klepper wishes satire was harder in age of Trump
Israeli desert town aims to be medical 'cannabis capital'
In Israel's Negev desert, far from the skyscrapers of Tel Aviv, the town of Yeruham hopes to cultivate an international reputation as the country's medical cannabis technology powerhouse.
Dozens of start-ups are already working on medical cannabis in Israel, where new legislation is expected to lead to further market growth in the fast-expanding sector.
Some believe that cannabis could help Yeruham tackle unemployment among its 12,000 residents, with initial efforts being led by a firm called CanNegev.
The company is known as an incubator, helping foster the growth of infant firms. CanNegev shelters four start-ups and is Israel's first medical cannabis technology incubator.
"We have decided to make medical cannabis the heart of our activity, here in Yeruham, one of the most peripheral towns in Israel -- a forgotten city," said CanNegev founder Zvi Bet Or.
He discovered a receptive audience in Tal Ohana, elected in 2018 to be Yeruham's first female mayor.
"My dream is to make Yeruham the capital of medical cannabis in Israel," Ohana told AFP.
"It's not every day that a new market is born" in the country, added Ohana, 37. "I told myself I have to do everything to be at the avant-garde of science and technology in this field."
CanNegev's modern building, facing the desert sands, stands out almost like a mirage, a symbol of the hoped-for future in the town whose stuccoed blocks of social housing were built in the 1950s for newly arrived immigrants.
But Yeruham is part of an economic priority zone that offers concessions to firms willing to set up there.
Ohana said the cannabis tech sector could transform the image of her town and help bring down its persistently higher-than-average unemployment, which is around eight percent.
"My goal is to create quality jobs" and to offer high incomes to attract a new population of workers, she said.
- World's leading importer -
Recreational use of cannabis is illegal though tolerated in Israel. However, authorities have encouraged its therapeutic use for the past decade to treat severe medical conditions and post-traumatic stress in former soldiers.
In October, Israel's parliament advanced a bill aimed at making medical cannabis more available.
It would expand a market that has already drawn scores of entrepreneurs including two former prime ministers: Ehud Olmert is business adviser to UNIVO Pharmaceuticals, and Ehud Barak chairs the board of InterCure.
About 100 start-ups are working on cannabis, said Dana Gourevich, Chief Technology Officer at the Israel Innovation Authority, adding that a quarter of those companies were founded in a single year, 2019.
"The medical cannabis ecosystem has received $60 million in investments in recent years," said Gourevich.
She said a key factor in developing Israel's homegrown cannabis industry was imports from overseas, especially Canada, where recreational use is legal.
According to health ministry data, Israel imported 22 tonnes of medical cannabis in 2021 compared to just over 14 tonnes a year before, making it the world's largest importer, the Israeli Cannabis Magazine noted.
By contrast, exporting cannabis is legal in theory but faces significant hurdles complying with international standards, Gourevich said.
- CBD for all -
The health ministry recently indicated it was examining the possibility of removing cannabidiol (CBD) from the list of dangerous drugs. The measure could open a new arena for companies to market CBD products at scale.
In southern Israel, near the city of Ashdod, BOL Pharma grows 400,000 cannabis plants annually on 3.5 hectares (8.6 acres), exclusively for therapeutic use.
"About 110,000 patients have (medical cannabis) licences today in Israel, but when CBD becomes available to everyone, millions of people, families, will be able to use it in cosmetics and everyday products," said Dvir Taler, 50, director of agriculture at BOL Pharma.
The company, currently the largest in the field of medical cannabis in Israel, partnered with the CanNegev incubator and supplies it with cannabis flowers for scientific experiments.
Taler said the incubator is developing a robot capable of autonomously harvesting flowers.
In its drive to become Israel's hub for green gold, the municipality of Yeruham has also allocated 50 hectares for the cultivation of medical cannabis, arguing that the desert climate is ideal for the crop's cultivation.
The user of that plot has not yet been determined.
Agreements have also been reached for two factories manufacturing non-medical cannabis products -- "self-care" goods such as oils used for cosmetics -- to be set up in Yeruham in the coming years, Ohana, the mayor said.
Resident Avraham Elbaz, 67, a retiree, said that "of course" he was in favour of these factories, which would help create jobs -- though he had not tried cannabis before.
"I have never smoked," he said.
W.Lapointe--BTB